ecrin-mdr-crcClinical2014Colorectal CancerHead and Neck CancerColorectal NeoplasmsHead and Neck NeoplasmsColorectal CancerColorectal NeoplasmsHead And Neck NeoplasmsHead And Neck CancerInterventionalhttps://newmdr.ecrin.org/Study/2164428United States4CetuximabECRIN MDRCompletedfalseCombination Study of Urelumab and Cetuximab in Patients With Advanced/Metastatic Colorectal Cancer or Advanced/Metastatic Head and Neck CancerThe purpose of the study is to determine the safety, tolerability and maximum tolerated dose of Urelumab in combination with Cetuximab in patients with Advanced/Metastatic Colorectal Cancer or Advanced/Metastatic Squamous Cell Carcinoma of the Head and Neck.2014-04-152164428NCT02110082